188 related articles for article (PubMed ID: 18629572)
21. Fracture prevention in postmenopausal women.
Mosekilde L; Vestergaard P; Langdahl B
Am Fam Physician; 2008 May; 77(10):1447-8. PubMed ID: 18533379
[No Abstract] [Full Text] [Related]
22. Effectiveness and safety of vitamin D in relation to bone health.
Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
[TBL] [Abstract][Full Text] [Related]
23. Osteoporosis and fracture risk in women of different ethnic groups.
Barrett-Connor E; Siris ES; Wehren LE; Miller PD; Abbott TA; Berger ML; Santora AC; Sherwood LM
J Bone Miner Res; 2005 Feb; 20(2):185-94. PubMed ID: 15647811
[TBL] [Abstract][Full Text] [Related]
24. Comparison of fracture risk prediction by the US Preventive Services Task Force strategy and two alternative strategies in women 50-64 years old in the Women's Health Initiative.
Crandall CJ; Larson JC; Watts NB; Gourlay ML; Donaldson MG; LaCroix A; Cauley JA; Wactawski-Wende J; Gass ML; Robbins JA; Ensrud KE
J Clin Endocrinol Metab; 2014 Dec; 99(12):4514-22. PubMed ID: 25322268
[TBL] [Abstract][Full Text] [Related]
25. Predicting Fracture Risk in Younger Postmenopausal Women: Comparison of the Garvan and FRAX Risk Calculators in the Women's Health Initiative Study.
Crandall CJ; Larson J; LaCroix A; Cauley JA; LeBoff MS; Li W; LeBlanc ES; Edwards BJ; Manson JE; Ensrud K
J Gen Intern Med; 2019 Feb; 34(2):235-242. PubMed ID: 30334182
[TBL] [Abstract][Full Text] [Related]
26. Elevated incidence of fractures in women with invasive breast cancer.
Edwards BJ; Gradishar WJ; Smith ME; Pacheco JA; Holbrook J; McKoy JM; Nardone B; Tica S; Godinez-Puig V; Rademaker AW; Helenowski IB; Bunta AD; Stern PH; Rosen ST; West DP; Guise TA
Osteoporos Int; 2016 Feb; 27(2):499-507. PubMed ID: 26294292
[TBL] [Abstract][Full Text] [Related]
27. Effects of self-reported age at nonsurgical menopause on time to first fracture and bone mineral density in the Women's Health Initiative Observational Study.
Sullivan SD; Lehman A; Thomas F; Johnson KC; Jackson R; Wactawski-Wende J; Ko M; Chen Z; Curb JD; Howard BV
Menopause; 2015 Oct; 22(10):1035-44. PubMed ID: 25803670
[TBL] [Abstract][Full Text] [Related]
28. Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: results from the Women's Health Initiative observational study and clinical trials.
Chen Z; Kooperberg C; Pettinger MB; Bassford T; Cauley JA; LaCroix AZ; Lewis CE; Kipersztok S; Borne C; Jackson RD
Menopause; 2004; 11(3):264-74. PubMed ID: 15167305
[TBL] [Abstract][Full Text] [Related]
29. Association between post-stroke disability and 5-year hip-fracture risk: The Women's Health Initiative.
Northuis CA; Crandall CJ; Margolis KL; Diem SJ; Ensrud KE; Lakshminarayan K
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104976. PubMed ID: 32689623
[TBL] [Abstract][Full Text] [Related]
30. A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.
Stevenson M; Jones ML; De Nigris E; Brewer N; Davis S; Oakley J
Health Technol Assess; 2005 Jun; 9(22):1-160. PubMed ID: 15929857
[TBL] [Abstract][Full Text] [Related]
31. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.
Anderson GL; Limacher M; Assaf AR; Bassford T; Beresford SA; Black H; Bonds D; Brunner R; Brzyski R; Caan B; Chlebowski R; Curb D; Gass M; Hays J; Heiss G; Hendrix S; Howard BV; Hsia J; Hubbell A; Jackson R; Johnson KC; Judd H; Kotchen JM; Kuller L; LaCroix AZ; Lane D; Langer RD; Lasser N; Lewis CE; Manson J; Margolis K; Ockene J; O'Sullivan MJ; Phillips L; Prentice RL; Ritenbaugh C; Robbins J; Rossouw JE; Sarto G; Stefanick ML; Van Horn L; Wactawski-Wende J; Wallace R; Wassertheil-Smoller S;
JAMA; 2004 Apr; 291(14):1701-12. PubMed ID: 15082697
[TBL] [Abstract][Full Text] [Related]
32. Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the women's health initiative randomized trial.
Jackson RD; Wactawski-Wende J; LaCroix AZ; Pettinger M; Yood RA; Watts NB; Robbins JA; Lewis CE; Beresford SA; Ko MG; Naughton MJ; Satterfield S; Bassford T;
J Bone Miner Res; 2006 Jun; 21(6):817-28. PubMed ID: 16753012
[TBL] [Abstract][Full Text] [Related]
33. Bone Mineral Density as a Predictor of Subsequent Wrist Fractures: Findings From the Women's Health Initiative Study.
Crandall CJ; Hovey KM; Andrews CA; Cauley JA; Manson JE; Wactawski-Wende J; Wright NC; Li W; Beavers K; Curtis JR; LeBoff MS
J Clin Endocrinol Metab; 2015 Nov; 100(11):4315-24. PubMed ID: 26367200
[TBL] [Abstract][Full Text] [Related]
34. Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO).
Cooper C; Jakob F; Chinn C; Martin-Mola E; Fardellone P; Adami S; Thalassinos NC; Melo-Gomes J; Torgerson D; Gibson A; Marin F
Osteoporos Int; 2008 Apr; 19(4):493-501. PubMed ID: 17968611
[TBL] [Abstract][Full Text] [Related]
35. Serial Bone Density Measurement and Incident Fracture Risk Discrimination in Postmenopausal Women.
Crandall CJ; Larson J; Wright NC; Laddu D; Stefanick ML; Kaunitz AM; Watts NB; Wactawski-Wende J; Womack CR; Johnson KC; Carbone LD; Jackson RD; Ensrud KE
JAMA Intern Med; 2020 Sep; 180(9):1232-1240. PubMed ID: 32730575
[TBL] [Abstract][Full Text] [Related]
36. Association between soft drink consumption and osteoporotic fractures among postmenopausal women: the Women's Health Initiative.
Kremer PA; Laughlin GA; Shadyab AH; Crandall CJ; Masaki K; Orchard T; Snetselaar L; LaCroix AZ
Menopause; 2019 Nov; 26(11):1234-1241. PubMed ID: 31613830
[TBL] [Abstract][Full Text] [Related]
37. Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA.
Dawson-Hughes B; Tosteson AN; Melton LJ; Baim S; Favus MJ; Khosla S; Lindsay RL;
Osteoporos Int; 2008 Apr; 19(4):449-58. PubMed ID: 18292975
[TBL] [Abstract][Full Text] [Related]
38. Women's perspectives regarding osteoporosis, fracture risk, and pharmacologic treatment: a cross-sectional study.
Billington EO; Miyagishima RC; Hasselaar C; Arain M
Osteoporos Int; 2023 Dec; 34(12):2069-2076. PubMed ID: 37608123
[TBL] [Abstract][Full Text] [Related]
39. Identification of osteopenic women at high risk of fracture: the OFELY study.
Sornay-Rendu E; Munoz F; Garnero P; Duboeuf F; Delmas PD
J Bone Miner Res; 2005 Oct; 20(10):1813-9. PubMed ID: 16160738
[TBL] [Abstract][Full Text] [Related]
40. Minimal-trauma fracture in women with breast cancer surviving for at least 5 years from diagnosis.
Robinson PJ; Bell RJ; Zecena Morales CS; Fradkin P; Davis SR
Osteoporos Int; 2015 Feb; 26(2):795-800. PubMed ID: 25358797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
